Establishing a Model of Zika Virus-Induced Neurodegeneration in an Adult Mouse
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 3:10 min • July 8th, 2025
Loading...
Overview
This article demonstrates a protocol for establishing mouse models of Zika virus-induced neurological disorders using intracerebral injection strategies. The procedure involves precise stereotaxic injection of Zika virus suspension into the brain of adult mice, leading to neurodegeneration through infection of neural progenitor and glial cells. This model enables the study of Zika virus neuropathogenesis and the cellular mechanisms underlying virus-induced brain injury.
Key Study Components
Area of Science
- Neuroscience
- Virology
- Animal models
Background
- Zika virus infection is associated with neurological disorders and neurodegeneration.
- Mouse models are essential for studying the mechanisms of Zika virus-induced brain injury.
- Intracerebral injection allows targeted delivery of virus to specific brain regions.
- Understanding virus-host interactions in the brain can inform therapeutic strategies.
Purpose of Study
- To establish a reproducible mouse model for Zika virus-induced neurodegeneration.
- To detail the intracerebral injection technique for adult mice.
- To observe the cellular and immune responses following Zika virus infection in the brain.
Methods Used
- Anesthetize and secure adult mice in a stereotaxic frame with a heating pad.
- Surgically expose the skull, identify bregma, and drill a hole at the target site using stereotaxic coordinates.
- Inject 1 microliter of Zika virus suspension into the brain at a controlled rate using a microinjector and gas-tight syringe.
- Suture the scalp and monitor mice during recovery.
Main Results
- Zika virus reaches the subventricular zone, infecting neural progenitor and glial cells.
- Viral replication induces cellular stress and apoptosis in neural cells.
- Microglia respond by engulfing virus, producing oxidative bursts, and releasing cytokines and neurotoxic factors.
- Recruitment of cytotoxic T-cells and depletion of neural progenitor and glial cells result in neurodegeneration.
Conclusions
- The described protocol reliably induces Zika virus-mediated neurodegeneration in adult mice.
- This model is valuable for studying the neuropathological mechanisms of Zika virus infection.
- It provides a platform for testing potential therapeutic interventions targeting virus-induced brain injury.
Frequently Asked Questions
What is the main purpose of intracerebral injection in this protocol?
The main purpose is to deliver Zika virus directly into the mouse brain to model virus-induced neurodegeneration and study the resulting cellular and immune responses.
How is the injection site determined during the procedure?
The injection site is identified using the bregma as a landmark and stereotaxic coordinates to ensure precise targeting of the desired brain region.
What volume and rate of Zika virus suspension is injected?
A total of 1 microliter of Zika virus suspension is injected at a rate of 10 nanoliters per second over 1.5 minutes.
What are the key cellular targets of Zika virus in this model?
The virus primarily infects neural progenitor cells and glial cells in the subventricular zone of the brain.
How does the immune system respond to Zika virus infection in the brain?
Microglia engulf the virus, produce oxidative bursts, and release cytokines and neurotoxic factors, which recruit cytotoxic T-cells to eliminate infected cells, contributing to neurodegeneration.
What are the main signs of neurodegeneration observed in this model?
Depletion of neural progenitor and glial cells, increased apoptosis, and tissue damage due to immune responses are key indicators of neurodegeneration following infection.
Why is this mouse model important for Zika virus research?
It enables controlled study of Zika virus neuropathogenesis and provides a platform for evaluating potential treatments for virus-induced neurological disorders.
Executive Industry Relevance
Establishing an adult mouse model of Zika virus-induced neurodegeneration enables rigorous interrogation of viral neuropathogenesis and immune-mediated injury in a controlled, reproducible system. This model supports predictive confidence in target validation and mechanistic de-risking for neuroinflammatory and antiviral therapeutic strategies. Its relevance spans early discovery through preclinical evaluation, informing portfolio decisions for neurovirology programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct testing of neurodegenerative hypotheses linked to Zika virus infection.
- Clarifies cellular mechanisms of neural progenitor and glial cell depletion.
- Supports functional target validation for antiviral and neuroprotective interventions.
- Facilitates mechanistic de-risking by modeling immune-mediated neural injury.
Screening & Assay Development
- Provides a validated in vivo system for evaluating candidate compounds targeting viral replication or neuroinflammation.
- Supports quantitative assessment of neurodegeneration and immune cell recruitment.
- Enables reproducible measurement of apoptosis and neural cell loss as assay endpoints.
- Prepares a platform for scalable compound screening in disease-relevant context.
Translational & Preclinical Research
- Aligns with translational biomarker development by modeling human-relevant neurodegenerative processes.
- Ensures continuity from mechanistic discovery to preclinical efficacy testing.
- Supports risk-adjusted advancement of neuroprotective and antiviral candidates.
- Provides predictive value for therapeutic impact on virus-induced brain injury.
Pipeline & Workflow Integration
This model integrates into the discovery-to-preclinical continuum, bridging mechanistic studies and translational validation for neurovirology portfolios.
- Discovery Biology: Enables hypothesis-driven testing of viral and immune mechanisms underlying neurodegeneration.
- Screening: Delivers reproducible, quantitative readouts for compound efficacy against neural cell loss and inflammation.
- Analytics: Supports statistical comparison of neurodegenerative endpoints across experimental conditions.
- Translational Research: Models disease-relevant neural injury for biomarker and therapeutic alignment.
- Enterprise Reuse: Functions as a reusable platform for diverse neuroinflammatory and antiviral research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic understanding of neurodegeneration.
- Operational Value: Standardizes in vivo neurodegeneration modeling for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and reduces late-stage biological risk in neurovirology pipelines.
- Portfolio Impact: Enables risk-adjusted prioritization of therapeutic candidates targeting virus-induced neural injury.
Implementation Considerations
- Requires expertise in stereotaxic surgery and neuroanatomical targeting.
- Demands access to microinjection instrumentation and animal surgical infrastructure.
- Necessitates cross-team standardization of injection coordinates and post-injection monitoring.
- Adaptation may be needed for different viral strains or mouse backgrounds.
- Limitations include model specificity to acute neurodegeneration and immune response dynamics.
Biopharma FAQs
Why does null hypothesis testing matter for Zika-induced neurodegeneration models?
Null hypothesis testing enables objective evaluation of whether Zika virus exposure causes statistically significant neurodegeneration compared to controls, supporting robust target validation and mechanistic clarity in neurovirology research.
How does independent variable isolation fit the intracerebral injection workflow?
Isolating the independent variable—Zika virus administration—ensures that observed neurodegenerative outcomes are attributable to viral infection rather than procedural artifacts, strengthening mechanistic de-risking and experimental interpretability.
What do quantitative measurements of neural cell loss enable in this model?
Quantitative assessment of neural progenitor and glial cell depletion provides actionable endpoints for comparing intervention efficacy, supporting data-driven advancement decisions in neuroprotective and antiviral candidate screening.
Why are replication requirements critical for cross-functional neurovirology teams?
Replication ensures that neurodegenerative and immune response findings are reproducible across studies and teams, enabling reliable data integration and collaborative decision-making in multi-disciplinary R&D environments.
Which statistical analysis capabilities are required before preclinical implementation?
Robust statistical analysis of neurodegeneration, apoptosis, and immune cell recruitment is essential to validate model outputs, guide threshold setting, and support translational continuity from discovery to preclinical development.
10:27
Zika Virus Infection of Cultured Human Fetal Brain Neural Stem Cells for Immunocytochemical Analysis
Related Videos
0 Views
10:01
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Related Videos
0 Views
10:31
Isolation and Quantification of Zika Virus from Multiple Organs in a Mouse
Related Videos
0 Views
02:47
Developing an In Vitro Model of Zika Virus Infection in Cerebral Organoids
Related Videos
0 Views
02:47
Establishing an Alzheimer's Disease Model in Zebrafish Brain Through Amyloid Peptide Injection
Related Videos
0 Views
02:21
Generation of a Murine Model with a Central Nervous System Infection
Related Videos
0 Views
02:21
Zika Virus Infection of Fetal Neural Stem Cells
Related Videos
0 Views
10:01
Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain
Related Videos
0 Views
09:18
Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids
Related Videos
0 Views
09:39
Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
Related Videos
0 Views
Last updated: 15 August 2026